Reply: Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?

Inflamm Bowel Dis. 2024 Oct 3;30(10):1928-1930. doi: 10.1093/ibd/izae130.
No abstract available

Publication types

  • Letter
  • Editorial
  • Comment

MeSH terms

  • Azathioprine / adverse effects
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Inflammatory Bowel Diseases* / drug therapy
  • Mercaptopurine* / adverse effects
  • Mercaptopurine* / therapeutic use
  • Prognosis

Substances

  • Mercaptopurine
  • Immunosuppressive Agents
  • Azathioprine